000 01134 a2200313 4500
005 20250516084857.0
264 0 _c20121010
008 201210s 0 0 eng d
022 _a1432-0878
024 7 _a10.1007/s00441-012-1377-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBanno, Haruhiko
245 0 0 _aPathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
_h[electronic resource]
260 _bCell and tissue research
_cJul 2012
300 _a313-20 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aBulbo-Spinal Atrophy, X-Linked
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aLeuprolide
_xtherapeutic use
650 0 4 _aMolecular Targeted Therapy
700 1 _aKatsuno, Masahisa
700 1 _aSuzuki, Keisuke
700 1 _aTanaka, Fumiaki
700 1 _aSobue, Gen
773 0 _tCell and tissue research
_gvol. 349
_gno. 1
_gp. 313-20
856 4 0 _uhttps://doi.org/10.1007/s00441-012-1377-9
_zAvailable from publisher's website
999 _c21678837
_d21678837